BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26665891)

  • 1. Earlier Access to Hospice Care Might Improve End-of-Life Care for West Virginia's Elders.
    Zinn C
    W V Med J; 2015; 111(6):16-7. PubMed ID: 26665891
    [No Abstract]   [Full Text] [Related]  

  • 2. A new medicare end-of-life benefit for nursing home residents.
    Huskamp HA; Stevenson DG; Chernew ME; Newhouse JP
    Health Aff (Millwood); 2010; 29(1):130-5. PubMed ID: 20048371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating care at the end of life: should Medicare Advantage include hospice?
    Stevenson DG; Huskamp HA
    JAMA; 2014 Apr; 311(15):1493-4. PubMed ID: 24633593
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing the value of hospice care: is documentation of cost savings necessary.
    Biskupiak J; Korner E
    J Pain Palliat Care Pharmacother; 2005; 19(4):61-5. PubMed ID: 16431834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on end-of-life care. Foundation awards grants to improve care programs.
    Katzman CN
    Mod Healthc; 1998 Nov; 28(45):56. PubMed ID: 10187322
    [No Abstract]   [Full Text] [Related]  

  • 6. Hospice use and public expenditures at the end of life in assisted living residents in a Florida Medicaid waiver program.
    Meng H; Dobbs D; Wang S; Hyer K
    J Am Geriatr Soc; 2013 Oct; 61(10):1777-81. PubMed ID: 24117288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stats and facts. Costs at the end of life.
    Manag Care Interface; 1999 Aug; 12(8):40-1. PubMed ID: 10621090
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing end-of-life care revenue cycle processes.
    Snyder R
    Revenue-cycle Strateg; 2015 Feb; 12(1):1-4. PubMed ID: 25816486
    [No Abstract]   [Full Text] [Related]  

  • 9. Palliative and end-of-life care: policy analysis.
    Reb AM
    Oncol Nurs Forum; 2003; 30(1):35-50. PubMed ID: 12515982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative care: the legal & regulatory requirements.
    Raffa CA
    Caring; 2003 Nov; 22(11):6-9. PubMed ID: 14658196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in end of life care.
    Meier DE
    BMJ; 2004 May; 328(7449):E296-7. PubMed ID: 15142948
    [No Abstract]   [Full Text] [Related]  

  • 12. When hospice is the best option: an opportunity to redefine goals.
    Prince-Paul M
    Oncology (Williston Park); 2009 Apr; 23(4 Suppl Nurse Ed):13-7. PubMed ID: 19856592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved end-of-life care proves worthwhile, even at higher cost.
    Exec Solut Healthc Manag; 1998 Sep; 1(7):17-9. PubMed ID: 10185390
    [No Abstract]   [Full Text] [Related]  

  • 14. New paths in end-of-life care.
    Burnside G
    Health Prog; 1998; 79(3):18-20. PubMed ID: 10180014
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving the quality of life at the end of life.
    Rubin R
    JAMA; 2015 Jun; 313(21):2110-2. PubMed ID: 26034943
    [No Abstract]   [Full Text] [Related]  

  • 16. Barriers to quality end-of-life care in West Virginia ICU units: physicians' and nurses' prospectives.
    Moss AH; Demanelis AR; Murray J; Jack J
    W V Med J; 2005; 101(5):200-4. PubMed ID: 16422267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospice care in a commercial preferred provider organization population in Tennessee.
    Coulter SL; Melvin T; Carden JP; Mathis RS
    Am J Hosp Palliat Care; 2015 Mar; 32(2):168-72. PubMed ID: 24249830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospice and palliative care: program needs and academic issues.
    von Gunten CF; Neely KJ; Martinez J
    Oncology (Williston Park); 1996 Jul; 10(7):1070-4; discussion 1074, 1079-80. PubMed ID: 8837122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the Last Acts campaign: how can we improve?
    Karani R; Meier DE
    J Support Oncol; 2003; 1(1):69-72. PubMed ID: 15352649
    [No Abstract]   [Full Text] [Related]  

  • 20. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents.
    Shugarman LR; Bird CE; Schuster CR; Lynn J
    J Womens Health (Larchmt); 2007 Mar; 16(2):214-27. PubMed ID: 17388738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.